Magnolia Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$879K Sell
2,427
-7
-0.3% -$2.4K 0.15% 160
2026
Q1
$856K Buy
+2,434
New +$868K 0.17% 146
2024
Q4
Sell
-892
Closed -$287K 231
2024
Q3
$287K Buy
892
+225
+34% +$73.6K 0.14% 120
2024
Q2
$208K Buy
+667
New +$196K 0.12% 117
2021
Q2
Sell
-3,505
Closed -$872K 145
2021
Q1
$872K Buy
3,505
+2,384
+213% +$569K 1.72% 18
2020
Q4
$258K Buy
1,121
+176
+19% +$40.6K 0.17% 93
2020
Q3
$240K Buy
+945
New +$234K 0.19% 87

Other funds holding AMGN

Magnolia Capital Advisors's AMGN Position: Q2 2026 in Review

Magnolia Capital Advisors reduced its Amgen (AMGN) stake by 0.29% in Q2 2026, selling an estimated $2.4K and leaving 2,427 shares worth $879K. The position accounts for 0.15% of the portfolio, ranked #160.

Magnolia Capital Advisors first reported a position in AMGN in Q3 2020 and has held it in 7 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Magnolia Capital Advisors held 2,427 shares of Amgen worth $879K as of Q2 2026.
  • Magnolia Capital Advisors sold 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 0.15% of Magnolia Capital Advisors's portfolio in Q2 2026, its #160 holding.
  • Magnolia Capital Advisors first reported a position in Amgen in Q3 2020 and has held it in 7 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Magnolia Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.